Overview:

The global enteral nutrition market was valued at USD 7803.5 million in 2023 and is projected to reach USD 8693.3 million in 2025. This market is expected to expand at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2025 to 2035, with sales anticipated to hit USD 15699.5 million by 2035.

Growth in the enteral nutrition sector is primarily fueled by the rising prevalence of chronic medical conditions, a growing elderly population worldwide, and increased emphasis on clinical nutritional support for patients. Market participants such as Abbott, Nestlé, Danone, and Fresenius Kabi are actively investing in product formulation enhancements and technological advancements for feeding devices.

The shift from parenteral to enteral nutrition is also contributing to market expansion, driven by better patient outcomes and lower costs associated with enteral support. Furthermore, increased adoption of home-based enteral feeding technologies and awareness of the importance of specialized nutritional care in emerging economies are key market drivers.

The market encompasses a broad spectrum of products, including standard and disease-specific formulas designed for conditions such as diabetes, kidney disorders, and cancer. Innovations in product taste, nutrient density, and specialized formulations are catering to the diverse needs of patients and healthcare systems.

Leading companies are focusing on developing user-friendly solutions and expanding distribution channels to enhance accessibility for both clinical and home-based users. The competitive landscape is marked by continuous innovation in product composition and delivery methods.

Growing research highlighting the benefits of optimal nutrition in improving recovery rates and reducing hospital stays is further supporting the demand for enteral nutrition products. This is leading to greater integration of nutritional therapy into standard patient care protocols.